共 221 条
[1]
Selva-O'Callaghan A(2018)Classification and management of adult inflammatory myopathies Lancet Neurol 17 816-828
[2]
Pinal-Fernandez I(2016)Spectrum of immune-mediated necrotizing myopathies and their treatments Curr Opin Rheumatol 28 619-624
[3]
Trallero-Araguas E(2022)Performance of the 2017 European Alliance of Associations for Rheumatology/American College of Rheumatology classification criteria for idiopathic inflammatory myopathies in patients with myositis-specific autoantibodies Arthritis Rheumatol 74 508-517
[4]
Milisenda JC(2018)Immune-mediated necrotizing myopathy Curr Rheumatol Rep 20 21-2766
[5]
Grau-Junyent JM(2010)A novel autoantibody recognizing 200-kd and 100-kd proteins is associated with an immune-mediated necrotizing myopathy Arthritis Rheum. 62 2757-9511
[6]
Mammen AL(1986)Human autoantibodies reactive with the signal-recognition particle Proc Natl Acad Sci U S A. 83 9507-1454
[7]
Pinal-Fernandez I(2015)The prevalence of individual histopathologic features varies according to autoantibody status in muscle biopsies from patients with dermatomyositis J Rheumatol 42 1448-687
[8]
Mammen AL(2017)Thigh muscle MRI in immune-mediated necrotising myopathy: extensive oedema, early muscle damage and role of anti-SRP autoantibodies as a marker of severity Ann Rheum Dis 76 681-794
[9]
Casal-Dominguez M(2017)More severe disease and slower recovery in younger patients with anti-3-hydroxy-3-methylglutaryl-coenzyme A reductase-associated autoimmune myopathy Rheumatology (Oxford) 56 787-270
[10]
Pinal-Fernandez I(2017)Longitudinal course of disease in a large cohort of myositis patients with autoantibodies recognizing the signal recognition particle Arthritis Care Res (Hoboken). 69 263-293